Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Three Endpoints to Assess the Benefit of Rehabilitation in Patients With Advanced Non-small Cell Lung Cancer Controlled After at Least 6 Months of Systemic Treatment

NCT07434947 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.

NCT NCT07434947
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07434947 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Three Endpoints to Assess the Benefit of Rehabilitation in Patients With Advanced Non-small Cell Lung Cancer Controlled After at Least 6 Months of Systemic Treatment
Lead sponsor
University Hospital, Grenoble
Phase
Observational
Overall status
Recruiting
Start date
April 15, 2026
Completion date
October 14, 2027
Enrollment
63 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer (nsclc)